Pharma DRA (BioRadius) is a dedicated bioequivalence center providing clinical and bioanalytical services to pharmaceutical, medical and biotechnology companies internationally. Successful study requires scientifically sound study design. Our clinical pharmacology experts guide your product seamlessly through the clinical phase of the study and bring the best results to the table.
Our specialization includes:
Our CRO firm has conducted more than 150+ Studies for various international markets and regulatory bodies like US FDA, UK MHRA and EMA and can perform the following studies in-house:
- Single dose bioequivalence studies
- Multiple dose bioequivalence studies
- Steady-sate bioequivalence studies
- Food effect studies
Clinical Drug-Drug interaction (DDI) studies: Patients frequently use more than one medication at a time, thus investigating drug-drug interactions is essential to drug development. We have expertise in designing and analyzing DDI studies at all phases of development.
Md Mehedi Hasan
M.Pharm, Co-Ordinator, CRO & BE Study
Dr. Senthil Thyagarajan
Director and Head-CRO
Dr. Krishnaveni Gadiraju
Director, Operations & PM
